Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

111.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 148.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 41,504
  • Market Cap: £117.92m
  • RiskGrade: 281

Carpetright Chairman trades in 416,500 shares

Date: Thursday 17 Oct 2013

LONDON (ShareCast) - Lord Harris of Peckham, the Executive Chairman of Carpetright, this week reduced his stake in the flooring specialist with the sale of 416,500 shares.

The sale was made through his company Harris Ventures, which is also connected with Martin Harris, Carpetright's Group Development Director.

Harris Ventures disposed of the shares at 649.06p each, for a total trade value of £2.7m.

Lord Harris, who explained that the sale is for personal wealth management reasons, now owns 11.92m shares, equal to a 17.64% stake in the company.

The director, who has been with the retailer for 56 years, only became Executive Chairman at the start of this month, and previously held the role of Chief Executive before stepping down in May last year.

The sale was made just two weeks after the company revealed its full-year profit would be "significantly" below its previous expectations, hit by volatile UK trading, a decline in sales, and extremely difficult economic conditions in the Netherlands.


Top Director Buys

Redrow (RDW)
Director name: Mr Andrew Nicholas Hewson
Amount purchased: 7,750 @ 255.19p
Value: £19,777

Cello Group (CLL)
Director name: Mr Mark Bentley
Amount purchased: 17,724 @ 62.00p
Value: £10,989


Top Director Sells

Carpetright (CPR)
Director name: Mr Martin Harris
Amount sold: 416,500 @ 649.06p
Value: £2,703,335

Carpetright (CPR)
Director name: Mr Lord Philip Harris of Peckham
Amount sold: 416,500 @ 649.06p
Value: £2,703,335

Tasty (TAST)
Director name: Mr Daniel Jonathan Plant
Amount sold: 511,391 @ 100.00p
Value: £511,391

Goodwin Plc (GDWN)
Director name: Mr Richard S Goodwin
Amount sold: 9,000 @ 3,708.00p
Value: £333,720

Goodwin Plc (GDWN)
Director name: Mr John W Goodwin
Amount sold: 9,000 @ 3,708.00p
Value: £333,720

Tasty (TAST)
Director name: Mr Adam Kaye
Amount sold: 332,230 @ 100.00p
Value: £332,230

Tasty (TAST)
Director name: Mr Samuel Kaye
Amount sold: 332,230 @ 100.00p
Value: £332,230

Dairy Farm International Holdings Ltd. (Singapore) (DFI)
Director name: Mr Michael Kok
Amount sold: 28,800 @ $10.81
Value: $311,363

Bunzl (BNZL)
Director name: Mr Brian May
Amount sold: 19,343 @ 1,324.00p
Value: £256,101

Tasty (TAST)
Director name: Mr Keith Lassman
Amount sold: 163,910 @ 100.00p
Value: £163,910

NR

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 111.00p
Change Today -2.00p
% Change -1.77 %
52 Week High 148.50
52 Week Low 101.00
Volume 41,504
Shares Issued 106.23m
Market Cap £117.92m
RiskGrade 281

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.51% below the market average66.51% below the market average66.51% below the market average66.51% below the market average66.51% below the market average
67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average
Price Trend
46.34% above the market average46.34% above the market average46.34% above the market average46.34% above the market average46.34% above the market average
7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average
Income
9.26% below the market average9.26% below the market average9.26% below the market average9.26% below the market average9.26% below the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average
Growth
40.89% below the market average40.89% below the market average40.89% below the market average40.89% below the market average40.89% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 23-Apr-20 03-Oct-19
Paid 22-May-20 01-Nov-19
Amount 2.95p 1.15p

Trades for 01-Apr-2020

Time Volume / Share Price
11:59 9,298 @ 108.66p
11:34 4,240 @ 113.00p
09:49 966 @ 108.46p
08:14 12,000 @ 108.30p
08:14 12,000 @ 108.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page